The hedge fund’s shares of CHS are valued at $17.36 million.
CHS’ stock price has declined 40.9 percent since the end of January and is trending downward, according to the report.
More articles on healthcare finance:
UMC approves debt repayment plan for bankrupt children’s hospital
UPMC gets financial boost from insurance division
AHA: Proposal to reduce Medicare appeals backlog won’t solve problem
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
